Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SST With or Without Definitive Treatment in Metastatic Prostate Cancer
NCT03678025Phase 3Recruiting
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2018
- Primary completion
- Apr 2033
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial in prostate cancer (PCa) (3 arms), sponsored by SWOG Cancer Research Network. Primary endpoint: Overall Survival at 8 years. Started Sep 2018; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03678025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03678025.